Clinical neurorestorative cell therapies: Developmental process, current state and future prospective
Clinical cell therapies (CTs) for neurological diseases and cellular damage have been explored for more than 2 decades. According to the United States Food and Drug Administration, there are 2 types of cell categories for therapy, namely stem cell-derived CT products and mature/functionally differen...
Main Authors: | Hongyun Huang, Lin Chen, Gengsheng Mao, Hari Shanker Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Journal of Neurorestoratology |
Subjects: | |
Online Access: | https://www.sciopen.com/article/10.26599/JNR.2020.9040009 |
Similar Items
-
Why is olfactory neuroepithelium?
by: Hongyun Huang
Published: (2021-12-01) -
Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells
by: Xiao J, et al.
Published: (2017-09-01) -
Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2022)☆
by: Hongyun Huang, et al.
Published: (2022-09-01) -
Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version)
by: Hongyun Huang, et al.
Published: (2020-12-01) -
Clinical cell therapy guidelines for neurorestoration (China version 2016)
by: Huang H, et al.
Published: (2017-02-01)